International
Stem Cell Corporation’s (www.internationalstemcell.com) scientists presented pre-clinical research results at
the International Society for Stem Cell Research (ISSCR) 10th Annual Meeting. This
is the first time the ISSCR meeting has been held in Asia (Yokohama, Japan). The
Emperor and Empress of Japan even made a guest appearance at the Conference.
Our
scientists presented the latest advancements in our Parkinson’s disease
therapeutic program. We have derived A9 dopaminergic neurons from human
parthenogenetic stem cells (hpSC) and demonstrated that these neurons engraft,
survive in vivo, and release dopamine in an animal (rat) model of Parkinson’s
disease.
We
also presented the most recent data on the in vitro and in vivo
characterization of hpSC-derived hepatocytes generated as a treatment for
multiple liver disorders. These advancements represent an important milestone
in our regenerative medicine program and bring us closer to be able to treat
individuals suffering from various liver diseases.
I
think the Conference went well for us, as it exposed our research to some well-known
stem cell scientists and their feedback was both positive and, more importantly,
useful to us.
Forward-looking
Statements
Statements
pertaining to anticipated developments, the potential benefits of research
programs and new manufacturing technologies, and other opportunities for the
company and its subsidiaries, along with other statements about the future
expectations, beliefs, goals, plans, or prospects expressed by management
constitute forward-looking statements. Any statements that are not historical
fact (including, but not limited to statements that contain words such as
"will," "believes," "plans,"
"anticipates," "expects," "estimates,") should
also be considered to be forward-looking statements. Forward-looking statements
involve risks and uncertainties, including, without limitation, risks inherent
in the development and/or commercialization of potential products and
technologies regulatory approvals, need and ability to obtain future capital,
application of capital resources among competing uses, and maintenance of
intellectual property rights. Actual results may differ materially from the
results anticipated in these forward-looking statements and as such should be
evaluated together with the many uncertainties that affect the company's
business, particularly those mentioned in the cautionary statements found in
the company's Securities and Exchange Commission filings. The company disclaims
any intent or obligation to update forward-looking statements.
